The University of Queensland and Oxford Nanopore Technologies Announce Research Partnership

The University of Queensland has joined forces with Oxford Nanopore Technologies in a collaborative effort aimed at expediting research related to the quality control testing of mRNA vaccines.

Under this partnership, researchers at the University of Queensland, known as BASE researchers, will leverage the latest advancements in nanopore-based sequencing technology to enhance performance and significantly reduce the time required to assess the quality attributes of mRNA vaccines. This innovative approach is poised to simplify and bolster the quality assurance processes for mRNA-based vaccines and therapeutics, benefiting global manufacturing standards.

Currently, the analysis of mRNA vaccines and therapies relies on a multitude of diverse methods that can be both time-consuming and intricate, often incurring substantial costs. Furthermore, some of these methods may become outdated as the field advances. 

By adopting Oxford Nanopore Technologies sequencing, the research team can directly examine each individual mRNA vaccine molecule as it traverses a protein nanopore. This real-time analysis provides an instantaneous and precise measurement of the mRNA sequence's identity and integrity, offering a cutting-edge solution for quality control.

This partnership has the potential to reshape the landscape of mRNA-based medical products, ensuring their quality, safety, and effectiveness on a global scale.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!